课题基金 / 基金详情

项目摘要

项目成果

Fanxin Long的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Wnt signaling has emerged as a major target pathway for developing novel bone anabolic agents. Although promising therapeutics has entered clinical trials, our understanding about how Wnt signaling promotes bone anabolism remains incomplete. Nonetheless, a fundamental understanding of the mechanism is critical for rational design of the next generation of therapies. We have previously discovered that Wnt signaling reprograms cellular metabolism during osteoblast differentiation. In particular, Wnt stimulates both aerobic glycolysis and glutaminolysis. We have further demonstrated that the increase in glutaminolysis fulfills both energetic and biosynthetic needs of osteoblasts. Moreover, redirecting glycolysis away from lactate production with a small molecule diminishes Wnt-induced bone formation. However, it remains unknown how the glycolytic switch favoring lactate production contributes to bone anabolism in response to Wnt. Here we test the central hypothesis that Wnt-induced aerobic glycolysis promotes bone formation through stimulation of glutaminolysis. We test the hypothesis in three specific aims. Aim 1 genetically tests the effect of Ldha deletion on osteosclerosis caused by a mutation of Lrp5 in mice. Aim 2 specifically examines the relationship between glycolysis and glutaminolysis in both bone explants and primary cell cultures. Finally, in Aim 3 we will determine the efficacy of Ldha overexpression in promoting bone formation in both an ossicle implant model and transgenic mice. Successful completion of the proposal is expected to pave a new avenue for developing bone-enhancing drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Illuminating adipo-osteoprogenitors in the bone marrow
  • 批准号:
    10590788
  • 项目类别:
  • 资助金额:
    $46.19万
  • 财政年份:
    2023
  • 负责人:
    Fanxin Long
  • 依托单位:
The cell metabolism basis for bone complications in type I diabetes
  • 批准号:
    10397146
  • 项目类别:
  • 资助金额:
    $45.59万
  • 财政年份:
    2021
  • 负责人:
    Fanxin Long
  • 依托单位:
The cell metabolism basis for bone complications in type I diabetes
  • 批准号:
    10608948
  • 项目类别:
  • 资助金额:
    $45.79万
  • 财政年份:
    2021
  • 负责人:
    Fanxin Long
  • 依托单位:
The cell metabolism basis for bone complications in type I diabetes
  • 批准号:
    10210735
  • 项目类别:
  • 资助金额:
    $45.41万
  • 财政年份:
    2021
  • 负责人:
    Fanxin Long
  • 依托单位:
海外基金